These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 34649356)

  • 1. Oligonucleotide aptamers: Recent advances in their screening, molecular conformation and therapeutic applications.
    Xiao X; Li H; Zhao L; Zhang Y; Liu Z
    Biomed Pharmacother; 2021 Nov; 143():112232. PubMed ID: 34649356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial Intelligence in Aptamer-Target Binding Prediction.
    Chen Z; Hu L; Zhang BT; Lu A; Wang Y; Yu Y; Zhang G
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress of SELEX methods for screening nucleic acid aptamers.
    Zhu C; Feng Z; Qin H; Chen L; Yan M; Li L; Qu F
    Talanta; 2024 Jan; 266(Pt 1):124998. PubMed ID: 37527564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
    Zhong Y; Zhao J; Li J; Liao X; Chen F
    Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamers: a new class of oligonucleotides in the drug discovery pipeline?
    Dausse E; Da Rocha Gomes S; Toulmé JJ
    Curr Opin Pharmacol; 2009 Oct; 9(5):602-7. PubMed ID: 19717337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-SELEX optimization of aptamers.
    Gao S; Zheng X; Jiao B; Wang L
    Anal Bioanal Chem; 2016 Jul; 408(17):4567-73. PubMed ID: 27173394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.
    Rahimizadeh K; AlShamaileh H; Fratini M; Chakravarthy M; Stephen M; Shigdar S; Veedu RN
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Aptamer Discovery and Applications.
    Zhang Y; Lai BS; Juhas M
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30866536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SELEX Modifications and Bioanalytical Techniques for Aptamer-Target Binding Characterization.
    Tan SY; Acquah C; Sidhu A; Ongkudon CM; Yon LS; Danquah MK
    Crit Rev Anal Chem; 2016 Nov; 46(6):521-37. PubMed ID: 26980177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Better Aptamers: Structured Library Approaches, Selection Methods, and Chemical Modifications.
    Brown A; Brill J; Amini R; Nurmi C; Li Y
    Angew Chem Int Ed Engl; 2024 Apr; 63(16):e202318665. PubMed ID: 38253971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Highlight of Recent Advances in Aptamer Technology and Its Application.
    Sun H; Zu Y
    Molecules; 2015 Jun; 20(7):11959-80. PubMed ID: 26133761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current approaches in SELEX: An update to aptamer selection technology.
    Darmostuk M; Rimpelova S; Gbelcova H; Ruml T
    Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1141-61. PubMed ID: 25708387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving aptamer performance with nucleic acid mimics: de novo and post-SELEX approaches.
    Oliveira R; Pinho E; Sousa AL; DeStefano JJ; Azevedo NF; Almeida C
    Trends Biotechnol; 2022 May; 40(5):549-563. PubMed ID: 34756455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamers: selection, modification and application to nervous system diseases.
    Yang Y; Ren X; Schluesener HJ; Zhang Z
    Curr Med Chem; 2011; 18(27):4159-68. PubMed ID: 21838689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy.
    Fu Z; Xiang J
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical Modification of Aptamers for Increased Binding Affinity in Diagnostic Applications: Current Status and Future Prospects.
    Elskens JP; Elskens JM; Madder A
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Overview of Aptamer: The Prominent Applications and Different Computational Tools for its Design.
    Ameri M; Eskandari S; Nezafat N
    Curr Pharm Biotechnol; 2021; 22(10):1273-1286. PubMed ID: 33208068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.